Aegis Ventures and Northwell Holdings, the investment arm of the New York-based health system, on Tuesday launched Optain, a company that aims to use AI-backed retinal imaging to catch early signs of disease. The partners also provided an initial seed investment of $12 million.
Though the startup is new to the U.S. market, Aegis and Northwell said the tech can be traced back to Australian...
